CTRI/2021/06/034131招募中2 期
A Double blind, randomized, placebo controlled clinical trial to evaluate safety and efficacy of ShatPlus Advance in mild to moderate patients with COVID 19 disease. - Nil
BVG Life Sciences Ltd BVG Group0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age :18- 60 years (Both sex)
- •2.Confirmed COVID 19 diseases patient with positive RT-PCR
- •3.Mild to moderate disease (NEWS score <7) with or without comorbidity
- •4.Patients willing to provide consent and follow up for study duration
排除标准
- •1.Patients with compromised immunity, autoimmune disease or self-reports HIV or syphilis infection
- •2.Proves to be unfit for the study as per the investigatorâ??s discretion
- •3.Pregnant or lactating women
- •4.Requiring supplemental oxygen and ICU admission at screening
- •5.Known case of comorbidity which is uncontrolled and which in investigator discretion finds patients not suitable for the trial participation
- •6.Any other medical condition like History of MI, Epileptic episodes finding patients not fit for trial participation
研究者
相似试验
已完成
2 期
Clinical trial of ShatPlus in SARS-CoV-2 Infection.CTRI/2021/06/034132BVG Life Sciences Ltd BVG Group60
已完成
3 期
Clinical trial of GP/AYU/2021/001 Kit in patients with Covid 19.CTRI/2021/08/036010Mr Kamlesh Thummar300
招募中
4 期
Effect of Cannasen Nasal spray Night in SleepCTRI/2023/02/049401Cannordic A/S
已完成
3 期
A clinical trial to study the effectiveness and safety of Lanreotide injection in patients with carcinoid syndrome. Carcinoid syndrome is a group of symptoms associated with carcinoid tumors,such as diarrhea and/or flushing.CTRI/2011/04/001690Ipsen Pharma SAS100
已完成
不适用
A clinical study to assess effect of an herbal product in improving testosterone levels in healthy young malesCTRI/2018/11/016337aila Nutraceuticals120